Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MERCAPTOPURINE vs MESNA: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MERCAPTOPURINE vs MESNA: Safety Overview

Metric MERCAPTOPURINE MESNA
Total FAERS Reports 11,490 4,892
Deaths Reported 1,468 1,029
Death Rate 12.8% 21.0%
Hospitalizations 5,925 2,155
Average Patient Age 21.5 yrs 39.3 yrs
% Female Patients 43.8% 46.8%
FDA Approval Date Approved Prior to Jan 1, 1982 Apr 13, 2010
Manufacturer Florida Pharmaceutical Products, LLC Hikma Pharmaceuticals USA Inc.
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription